Article - European Medical Journal

Continue

Articles

Hepatology
27 May 2014

Use of HBSAG Quantification To Guide HBIG Prophylaxis After Liver Transplantation

Hepatitis B surface antigen (HBsAg) quantification has recently been introduced to guide treatment in chronic hepatitis B virus (HBV) patients.
Hepatology
27 May 2014

Cost-Effective Interventions in The Control of Chronic Hepatitis B (CHB) Infection

The hepatitis B virus (HBV) causes infection in the liver that can lead to cirrhosis, liver cancer, and premature death. The disease is not widely…
Hepatology
27 May 2014

Adipose Tissue, Metabolic Syndrome, and Non-Alcoholic Fatty Liver Disease – A Short Review

Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease globally, and it is expected to rise even further as a result of the…
Hepatology
27 May 2014

Overlapping Clinical Features Between NAFLD and Metabolic Syndrome in Children

Non-alcoholic fatty liver disease (NAFLD) is a cluster of pathological liver conditions of emerging importance in overweight and obese children.
Hepatology
27 May 2014

Translation From Mice to Men: Are Dogs a Dodgy Intermediate?

Alternatives for liver transplantation in severe liver disease are urgently needed in view of the limited availability of donor livers.
EMJ
Urology
5 May 2014

Robotic Radical Cystectomy for Bladder Cancer: Current Perspectives

The most effective local treatment of muscle invasive bladder cancer and non-invasive, high-grade bladder tumours that recur or progress despite…
EMJ
Urology
3 May 2014

Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer

Neoadjuvant chemotherapy (NAC) in muscle-invasive bladder cancer was introduced several years ago. Despite the evidence supporting its use in clinical…
EMJ
General Healthcare
2 Mins
1 Apr 2014

Adverse Events

A year after I graduated, I was working in an emergency department when one of my colleagues killed someone.
We’ve noticed you’re accessing
from North/South America.